Mycobacterium chimaera as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2021-09-01 Epub Date: 2021-09-17 DOI:10.33073/pjm-2021-028
Anna T Zabost, Monika Szturmowicz, Sylwia A Brzezińska, Magdalena D Klatt, Ewa M Augustynowicz-Kopeć
{"title":"<i>Mycobacterium chimaera</i> as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards.","authors":"Anna T Zabost,&nbsp;Monika Szturmowicz,&nbsp;Sylwia A Brzezińska,&nbsp;Magdalena D Klatt,&nbsp;Ewa M Augustynowicz-Kopeć","doi":"10.33073/pjm-2021-028","DOIUrl":null,"url":null,"abstract":"<p><p><i>Mycobacterium chimaera</i> is the newly described species belonging to <i>Mycobacterium avium</i> complex (MAC), with morphology and growth characteristics closely related to <i>Mycobacterium intracellulare</i>. The aim of this retrospective study was to analyze the frequency and clinical significance of <i>M. chimaera</i> identification in the population of patients with previous positive respiratory cultures for <i>M. intracellulare</i> or MAC. 200 strains of <i>M. intracellulare</i> or MAC, isolated from respiratory specimens of patients hospitalized in pulmonary wards, between 2011 and 2020, were retrospectively analyzed with GenoType NTM-DR test. 88 (44%) of strains were re-classified to <i>M. chimaera</i> species. Analysis of clinical data in 30 patients with positive <i>M. chimaera</i> isolates revealed that they were diagnosed with chronic obstructive pulmonary disease (COPD) - 27%, past tuberculosis - 20%, or interstitial lung diseases - 17%, respectively. Non-tuberculous mycobacterial lung disease (NTMLD) caused by <i>M. chimaera</i> has been recognized in 53% of patients, most often in those presenting with post-tuberculous lung lesions. <i>M. chimaera</i> was almost exclusively isolated from respiratory specimens of patients with underlying lung diseases, especially those with COPD and/or past tuberculosis. NTMLD due to <i>M. chimaera</i> was diagnosed predominantly in patients with past tuberculosis.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d9/ca/pjm-70-3-315.PMC8458994.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.33073/pjm-2021-028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/9/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 4

Abstract

Mycobacterium chimaera is the newly described species belonging to Mycobacterium avium complex (MAC), with morphology and growth characteristics closely related to Mycobacterium intracellulare. The aim of this retrospective study was to analyze the frequency and clinical significance of M. chimaera identification in the population of patients with previous positive respiratory cultures for M. intracellulare or MAC. 200 strains of M. intracellulare or MAC, isolated from respiratory specimens of patients hospitalized in pulmonary wards, between 2011 and 2020, were retrospectively analyzed with GenoType NTM-DR test. 88 (44%) of strains were re-classified to M. chimaera species. Analysis of clinical data in 30 patients with positive M. chimaera isolates revealed that they were diagnosed with chronic obstructive pulmonary disease (COPD) - 27%, past tuberculosis - 20%, or interstitial lung diseases - 17%, respectively. Non-tuberculous mycobacterial lung disease (NTMLD) caused by M. chimaera has been recognized in 53% of patients, most often in those presenting with post-tuberculous lung lesions. M. chimaera was almost exclusively isolated from respiratory specimens of patients with underlying lung diseases, especially those with COPD and/or past tuberculosis. NTMLD due to M. chimaera was diagnosed predominantly in patients with past tuberculosis.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
分枝杆菌嵌合是肺部病房住院患者NTM肺病的一个被低估的病因。
嵌合体分枝杆菌(Mycobacterium chimaera)是鸟分枝杆菌复合体(Mycobacterium avium complex, MAC)中新发现的一种,其形态和生长特征与胞内分枝杆菌密切相关。本回顾性研究的目的是分析细胞内支原体或MAC呼吸道培养阳性患者群体中嵌合支原体鉴定的频率及其临床意义。采用基因型NTM-DR试验对2011 - 2020年肺病房住院患者呼吸道标本中分离到的200株细胞内支原体或MAC进行回顾性分析。88株(44%)重新归类为嵌合体种。对30例chimaera阳性分离株患者的临床数据分析显示,他们分别被诊断为慢性阻塞性肺疾病(COPD) - 27%,既往结核病- 20%或间质性肺疾病- 17%。由嵌合分枝杆菌引起的非结核性分枝杆菌肺病(NTMLD)已在53%的患者中得到确认,最常见于结核后肺病变患者。嵌合分枝杆菌几乎完全从患有潜在肺部疾病的患者的呼吸道标本中分离出来,特别是那些患有慢性阻塞性肺病和/或既往结核病的患者。由chimaera引起的NTMLD主要在既往结核病患者中诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊最新文献
A Systematic Review of Sleep Disturbance in Idiopathic Intracranial Hypertension. Advancing Patient Education in Idiopathic Intracranial Hypertension: The Promise of Large Language Models. Anti-Myelin-Associated Glycoprotein Neuropathy: Recent Developments. Approach to Managing the Initial Presentation of Multiple Sclerosis: A Worldwide Practice Survey. Association Between LACE+ Index Risk Category and 90-Day Mortality After Stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1